Further evaluation of IGF-I responsiveness to ACTH in children affected with IGHD

D. Rossi, S. Longobardi, A. Selleri, V. Esposito, A. Colao, M. Cataldi, D. Ferone, G. Lombardi

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

In our previous studies we had demonstrated that, in children affected with isolated GH deficiency (IGHD), a short-term recombinant growth hormone (rGH) therapy increases the 11-deoxycortisol (S) secretion and induces an IGF-I responsiveness to the ACTH challenge. The aim of the present study was to further investigate the mechanisms by which IGF-I is secreted after ACTH challenge in children affected with IGHD by correlating IGF-I versus cortisol (F) time courses after ACTH administration. Ten children affected with IGHD were subjected to rGH therapy (4 IU/day subcutaneously) for 10 days. The responsiveness of IGF-I, F and S to the ACTH 1-17 test were evaluated before and at the end of the therapy. No IGF-I response to the ACTH test was recorded in the patients before the rGH treatment, whereas after rGH administration ACTH induced a significant IGF-I release (p <0.001) which started at the 1st hour, reached a peak value between the 5th and 6th hours and disappeared at the 10th hour. In conclusion, our study confirms that a short-term rGH therapy induces an IGF-I responsiveness to ACTH and helps to better define the kinetics and the mechanism of this IGF-I response to ACTH.

Original languageEnglish
Pages (from-to)150-153
Number of pages4
JournalHormone Research in Paediatrics
Volume38
Issue number3-4
DOIs
Publication statusPublished - 1992

Fingerprint

Pituitary Dwarfism
Insulin-Like Growth Factor I
Adrenocorticotropic Hormone
Growth Hormone
Cortodoxone
Therapeutics
Hydrocortisone

Keywords

  • ACTH
  • IGF-I
  • Isolated GH deficiency

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Pediatrics, Perinatology, and Child Health

Cite this

Rossi, D., Longobardi, S., Selleri, A., Esposito, V., Colao, A., Cataldi, M., ... Lombardi, G. (1992). Further evaluation of IGF-I responsiveness to ACTH in children affected with IGHD. Hormone Research in Paediatrics, 38(3-4), 150-153. https://doi.org/10.1159/000182531

Further evaluation of IGF-I responsiveness to ACTH in children affected with IGHD. / Rossi, D.; Longobardi, S.; Selleri, A.; Esposito, V.; Colao, A.; Cataldi, M.; Ferone, D.; Lombardi, G.

In: Hormone Research in Paediatrics, Vol. 38, No. 3-4, 1992, p. 150-153.

Research output: Contribution to journalArticle

Rossi, D, Longobardi, S, Selleri, A, Esposito, V, Colao, A, Cataldi, M, Ferone, D & Lombardi, G 1992, 'Further evaluation of IGF-I responsiveness to ACTH in children affected with IGHD', Hormone Research in Paediatrics, vol. 38, no. 3-4, pp. 150-153. https://doi.org/10.1159/000182531
Rossi D, Longobardi S, Selleri A, Esposito V, Colao A, Cataldi M et al. Further evaluation of IGF-I responsiveness to ACTH in children affected with IGHD. Hormone Research in Paediatrics. 1992;38(3-4):150-153. https://doi.org/10.1159/000182531
Rossi, D. ; Longobardi, S. ; Selleri, A. ; Esposito, V. ; Colao, A. ; Cataldi, M. ; Ferone, D. ; Lombardi, G. / Further evaluation of IGF-I responsiveness to ACTH in children affected with IGHD. In: Hormone Research in Paediatrics. 1992 ; Vol. 38, No. 3-4. pp. 150-153.
@article{1f2d6081fcdd447fb64361641b36ec44,
title = "Further evaluation of IGF-I responsiveness to ACTH in children affected with IGHD",
abstract = "In our previous studies we had demonstrated that, in children affected with isolated GH deficiency (IGHD), a short-term recombinant growth hormone (rGH) therapy increases the 11-deoxycortisol (S) secretion and induces an IGF-I responsiveness to the ACTH challenge. The aim of the present study was to further investigate the mechanisms by which IGF-I is secreted after ACTH challenge in children affected with IGHD by correlating IGF-I versus cortisol (F) time courses after ACTH administration. Ten children affected with IGHD were subjected to rGH therapy (4 IU/day subcutaneously) for 10 days. The responsiveness of IGF-I, F and S to the ACTH 1-17 test were evaluated before and at the end of the therapy. No IGF-I response to the ACTH test was recorded in the patients before the rGH treatment, whereas after rGH administration ACTH induced a significant IGF-I release (p <0.001) which started at the 1st hour, reached a peak value between the 5th and 6th hours and disappeared at the 10th hour. In conclusion, our study confirms that a short-term rGH therapy induces an IGF-I responsiveness to ACTH and helps to better define the kinetics and the mechanism of this IGF-I response to ACTH.",
keywords = "ACTH, IGF-I, Isolated GH deficiency",
author = "D. Rossi and S. Longobardi and A. Selleri and V. Esposito and A. Colao and M. Cataldi and D. Ferone and G. Lombardi",
year = "1992",
doi = "10.1159/000182531",
language = "English",
volume = "38",
pages = "150--153",
journal = "Hormone Research in Paediatrics",
issn = "1663-2818",
publisher = "S. Karger AG",
number = "3-4",

}

TY - JOUR

T1 - Further evaluation of IGF-I responsiveness to ACTH in children affected with IGHD

AU - Rossi, D.

AU - Longobardi, S.

AU - Selleri, A.

AU - Esposito, V.

AU - Colao, A.

AU - Cataldi, M.

AU - Ferone, D.

AU - Lombardi, G.

PY - 1992

Y1 - 1992

N2 - In our previous studies we had demonstrated that, in children affected with isolated GH deficiency (IGHD), a short-term recombinant growth hormone (rGH) therapy increases the 11-deoxycortisol (S) secretion and induces an IGF-I responsiveness to the ACTH challenge. The aim of the present study was to further investigate the mechanisms by which IGF-I is secreted after ACTH challenge in children affected with IGHD by correlating IGF-I versus cortisol (F) time courses after ACTH administration. Ten children affected with IGHD were subjected to rGH therapy (4 IU/day subcutaneously) for 10 days. The responsiveness of IGF-I, F and S to the ACTH 1-17 test were evaluated before and at the end of the therapy. No IGF-I response to the ACTH test was recorded in the patients before the rGH treatment, whereas after rGH administration ACTH induced a significant IGF-I release (p <0.001) which started at the 1st hour, reached a peak value between the 5th and 6th hours and disappeared at the 10th hour. In conclusion, our study confirms that a short-term rGH therapy induces an IGF-I responsiveness to ACTH and helps to better define the kinetics and the mechanism of this IGF-I response to ACTH.

AB - In our previous studies we had demonstrated that, in children affected with isolated GH deficiency (IGHD), a short-term recombinant growth hormone (rGH) therapy increases the 11-deoxycortisol (S) secretion and induces an IGF-I responsiveness to the ACTH challenge. The aim of the present study was to further investigate the mechanisms by which IGF-I is secreted after ACTH challenge in children affected with IGHD by correlating IGF-I versus cortisol (F) time courses after ACTH administration. Ten children affected with IGHD were subjected to rGH therapy (4 IU/day subcutaneously) for 10 days. The responsiveness of IGF-I, F and S to the ACTH 1-17 test were evaluated before and at the end of the therapy. No IGF-I response to the ACTH test was recorded in the patients before the rGH treatment, whereas after rGH administration ACTH induced a significant IGF-I release (p <0.001) which started at the 1st hour, reached a peak value between the 5th and 6th hours and disappeared at the 10th hour. In conclusion, our study confirms that a short-term rGH therapy induces an IGF-I responsiveness to ACTH and helps to better define the kinetics and the mechanism of this IGF-I response to ACTH.

KW - ACTH

KW - IGF-I

KW - Isolated GH deficiency

UR - http://www.scopus.com/inward/record.url?scp=0027007672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027007672&partnerID=8YFLogxK

U2 - 10.1159/000182531

DO - 10.1159/000182531

M3 - Article

C2 - 1339134

AN - SCOPUS:0027007672

VL - 38

SP - 150

EP - 153

JO - Hormone Research in Paediatrics

JF - Hormone Research in Paediatrics

SN - 1663-2818

IS - 3-4

ER -